Can better nutrition improve outcomes for head and neck cancer patients?
NCT ID NCT04436965
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase 3 trial tests whether a structured nutrition plan (including supplements, feeding tubes, or IV nutrition) helps malnourished patients with advanced nasopharyngeal carcinoma maintain weight and improve their prognosis. About 266 participants will receive either standard nutrition therapy or conventional nutrition advice alongside chemotherapy and radiation. The main goal is to see if fewer patients drop below 90% of their ideal body weight during treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- standardized nutrition therapy (oral supplements, feeding tube, or intravenous nutrition)
- What this could lead to
- If successful, this could show that structured nutrition support helps patients with nasopharyngeal carcinoma maintain weight and possibly improve treatment outcomes.
- What could go wrong
- This trial focuses on nutrition support, not a new drug or cure. It may not change survival or disease progression, and results may not apply to other cancers.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NASOPHARYNGEAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sun Yat-sen University Cancer Center
RECRUITINGGuangzhou, Guangdong, 510060, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could adding extra chemo before standard therapy beat nasopharyngeal cancer?
- Virtual cooking classes aim to boost health for hispanic prostate cancer survivors and their families
- Smart T-Cell engager aims to outsmart tumors in first human test
- Immunotherapy combo shows promise in shrinking Hard-to-Treat head and neck tumors
- Immunotherapy duo aims to shrink nasopharyngeal tumors before standard treatment
- New radiation approach aims to reduce dry mouth in throat cancer patients